Mad Money

Lightning Round: This one has too much exposure

It's that time again! The Lightning Round bell has rung, and Jim Cramer gives his take on a few favorite audience stocks:

Salesforce.com: "I think Salesforce is going to be okay...We are getting a little bit more buy in for the cloud plays, and I think you could be okay. Not sure, but okay."

State Bank Financial Corp: "The problem is that they missed the quarter, and a lot of other banks didn't miss the quarter."

Achillion Pharmaceuticals: "This is the Hep C company that has not been bought. So they have a Hep C formula and everyone keeps thinking that someone is going to buy them, I said recently that I think that's a very big price tag. So I don't know if it's worth the speculation."

----------------------------------------------------------
Read more from Mad Money with Jim Cramer
Cramer Remix: Get a piece of this
Cramer: 8 healthy market signs
Cramer is craving Shake Shack's IPO
----------------------------------------------------------

Martin Midstream Partners: "I'm worried about that one. I think that one has too much exposure. When I see that 10 percent yield

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com